You Can Rescue Medical Breakthroughs from the Valley of D...
·
Mar 29, 2018
When Kevin Leland's boss donated $500,000 to research in immunotherapy for gastric cancer, Leland wondered how he could d...
Open account
Oops! We couldn’t find any results...
Halo isn't accepting new investments
Explore new investment opportunities:
View companies raising now
Halo
A Sustainable Approach to Funding Research
Documents
Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Halo Cures, Inc. . View the official SEC filing and all updates:
Form C
SEC.gov
Company documents
Halo Crowd SAFE
Loading
Deal highlights
A Modern-Day
March for Dimes
In 1938, FDR founded the National Foundation for Infantile Paralysis to find a cure for polio. The entire nation mobilized behind the effort and people went door-to-door collecting dimes. Those dimes funded the research of Dr. Jonas Salk at the University of Pittsburgh where he ultimately discovered the polio vaccine.
Halo is a modern-day march for dimes.
Matching Donors with Promising Research
Each campaign Halo raises money for a defined research project that can help advance a promising discovery into a life-changing medical treatment. Halo reaches donors through joint marketing campaigns with relevant disease foundations and by marketing directly to likely donors through social and digital channels.
The Valley of Death
The problem Halo is addressing is known as "the valley of death” - the funding gap between basic research funded by government and clinical research funded by pharmaceutical companies. There are thousands of promising discoveries stuck at this crossroads – too advanced to be developed at the university but not advanced enough for a pharmaceutical company to shepherd forward.
This funding gap in “translational research” is one reason only a handful of new treatments are approved each year. And while clinical research costs millions, translational research is far less costly. A key study, for example, can take just 6 months and cost a few hundred thousand dollars.
The Halo Effect
To cross the valley, Halo connects the $390 billion individuals donate each year in the United States alone with research projects most likely to develop into patient treatments.
How it Works
FOR DONORS
A Sustainable Model for Research Funding
BUSINESS MODEL
Platform Tips: Halo suggests a voluntary 8% tip on top of each donation, which has become standard industry practice on fundraising platforms. Traditionally around 80% of donors tip. Campaigns also raise more money when donors know their entire contribution supports the cause.
Cashed-in Equity: Halo receives an equity stake in each company that successfully fundraises on the platform, which generates revenue upon a liquidation event. The investment horizon for a liquidation event is 2 - 3 years and takes the form of a sub-licensing agreement or secondary sales of private stock.
What People Are Saying
Collaboration Network for Drug Developers
LONG-TERM VISION
Halo’s long-term vision is to be more than a fundraising platform. A common strategy to solve the “chicken and egg” problem when building a professional network is known as “come for the tool, stay for the network.” Under this approach, users initially join to take advantage of a tool or feature, and then gradually discover and start interacting with other like-minded users on the network. Halo’s strategy can be described as “come for the funding, stay for the network.” Fundraising is a means to the end, but not the end itself.
The ultimate goal for Halo is to become a collaboration network for drug developers that addresses all three root causes of the valley of death - the funding gap, the knowledge gap and the talent gap. The knowledge gap is the skills-gap among academic scientists trained in basic research, but not translational research. The talent gap is the lack of business talent to lead early-stage biotech companies. We're starting with the funding gap, but Halo’s long-term vision is to unite academia and industry on a single platform.
Industry Landscape
Halo’s peer group consists of collaboration platforms and professional networks in healthcare and medicine.
The Halo Team
Halo was created by a talented team of scientists, engineers, designers and marketers representing a diverse range of educational backgrounds and work experiences.
Message from Founder
Hello, I'm Kevin Leland, CEO and Founder of Halo.
As a non-academic, I was generally familiar with how expensive and time-consuming it was to bring a new drug to market, but what I didn’t know was that the vast majority of these costs don’t come until late-stage clinical trials. Meanwhile, there were hundreds, perhaps thousands, of promising discoveries in a state of limbo – too advanced to be developed at the university but not advanced enough for a pharmaceutical company to shepherd forward.
This funding gap in “translational research” is what researchers refer to as "the valley of death" in drug development. What's more, translational research doesn't cost millions and take many years to complete like clinical research. A translational research project can can cost several hundred thousand dollars and take less than a year.
Join me and Halo in our mission to advance promising discoveries into effective treatments. With your support, we can create a sustainable model for research funding.
Thank you,
Kevin
Deal terms
Valuation cap
$3,000,000
The maximum valuation at which your investment converts
into equity shares or cash.
Learn more
Discount
20%
If a trigger event for Halo occurs, the discount provision
gives investors equity shares (or equal value in cash) at a reduced price.
Learn more.
Funding goal
$100K
Halo must achieve its minimum goal of $25K before the deadline. The maximum amount the offering can raise is $100K.
Learn more
Deadline
Halo needs to reach their minimum funding goal before the deadline
(
).
If they don’t, all investments will be refunded.
Learn more
Learn more
Type of security
Crowd SAFE
A SAFE allows an investor to make a cash investment in a company, with rights to receive certain company stock at a later date, in connection with a specific event.
·
Learn more
Documents
Republic (OpenDeal Portal LLC, CRD #283874) is hosting this Reg CF securities offering by Halo Cures, Inc. . View the official SEC filing and all updates:
Form C
SEC.gov
Company documents
Halo Crowd SAFE
Bonus perks
In addition to your Crowd SAFE, you'll receive perks for investing
in Halo.
Invest
$100
Receive
- Halo T-Shirt
Invest
$1,000
Receive
- VIP Ticket to the The Halos, an award show honoring heroes of medicine.
Invest
$5,000
Receive
- Limited Edition print from the "Beyond Curie" art exhibit designed by scientist, artists and TED Speaker Amanda Phingbodhipakkiya
Invest
$10,000
Receive
- Gold Sponsorship for The Halo Awards, event on August 1 in Chicago honoring "heroes of medicine," and recognition during opening remarks by event host
Invest
$15,000
Receive
- Commissioned project from scientist, artist and TED Speaker Amanda
Invest
$20,000
Receive
- Presenting Sponsorship for The Halo Awards, event on August 1 in Chicago honoring "heroes of medicine," and recognition during opening remarks by event host
About Halo
Legal Name
Halo Cures, Inc.
Founded
Jun 2016
Form
Delaware
Corporation
Headquarters
44 Montgomery Street
, San Francisco, CA
Headquarters
44 Montgomery Street, San Francisco, CA, United States 94104
Halo Team
Everyone helping build Halo, not limited to employees
Kevin Leland
Founder
Agam Patel
Back-End Developer
Emily Pidgeon
Creative Producer
Vincent Barr
Growth Marketing
Amy Kabaria
Legal
Devin Starks
Front-End Developer
Alicia Brooks
UX/UI Design
Wesley Drake
Visual Design
FAQ
How does Halo vet the research?
How does Halo vet the research?
Halo vets each research project through an external selection committee with experience evaluating both the clinical and commercial potential of early-stage research.
Why don’t pharmaceutical companies fund this research if it’s so promising?
Why don’t pharmaceutical companies fund this research if it’s so promising?
Pharmaceutical companies have increasingly focused their efforts on investing in research that has advanced much further along. As a result, many promising discoveries that could ultimately develop into patient treatments are unable to secure funding to move forward, resulting in a classic Catch-22.
How does Halo make money?
How does Halo make money?
Halo has two revenue streams:
Platform Tips: Halo suggests a voluntary 8% tip on top of each donation, which has become standard industry practice on fundraising platforms. Traditionally around 80% of donors tip. Campaigns also raise more money when donors know their entire contribution supports the cause.
Cashed-in Equity: Halo receives an equity stake in each company that successfully fundraises on the platform, which generates revenue upon a liquidation event. The investment horizon for a liquidation event is 2 - 3 years and takes the form of a sub-licensing agreement or secondary sales of private stock.
What if the fundraising goal is not met?
What if the fundraising goal is not met?
If the fundraising goal is not met, the funds are still disbursed to the research project. While the fundraising goal is based on a detailed third-party assessment of costs, any amount of funding is helpful and can be deployed elsewhere to advance the research. However, donors can still request a full refund within 30 days of payment.
What is Halo?
What is Halo?
Halo is a curated fundraising platform that presents donors with promising research targeting specific medical conditions.
Still have questions? Check the
discussion section.
Discussion
Ask questions and share feedback with the Halo team below.
If you have support related questions for Republic, please contact
investors@republic.co.
Loading
Invest in the app
Invest in startups using your credit card
